Guanhao Biotech Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
April 14, 2022 at 06:08 am EDT
Share
Guanhao Biotech Co.,Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 122.93 million compared to CNY 128.44 million a year ago. Net income was CNY 21.78 million compared to CNY 18.25 million a year ago. Basic earnings per share from continuing operations was CNY 0.08 compared to CNY 0.07 a year ago. Diluted earnings per share from continuing operations was CNY 0.08 compared to CNY 0.07 a year ago.
Guanhao Biotech Co., Ltd. is a China-based company principally engaged in the research, development, production and distribution of regeneration medical materials and medical implanted devices. The Company primarily provides biological dura mater patches, chest general surgery department patching membranes (type P) and (type B), asepsis biological wound-surface protection membranes, type B dura matrix, intraocular lens as well as agent products. The Company is also engaged in provision of related technological services.
GUANHAO BIOTECH CO.,LTD. 
